188 related articles for article (PubMed ID: 37210683)
21. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Al-Batran SE; Homann N; Pauligk C; Goetze TO; Meiler J; Kasper S; Kopp HG; Mayer F; Haag GM; Luley K; Lindig U; Schmiegel W; Pohl M; Stoehlmacher J; Folprecht G; Probst S; Prasnikar N; Fischbach W; Mahlberg R; Trojan J; Koenigsmann M; Martens UM; Thuss-Patience P; Egger M; Block A; Heinemann V; Illerhaus G; Moehler M; Schenk M; Kullmann F; Behringer DM; Heike M; Pink D; Teschendorf C; Löhr C; Bernhard H; Schuch G; Rethwisch V; von Weikersthal LF; Hartmann JT; Kneba M; Daum S; Schulmann K; Weniger J; Belle S; Gaiser T; Oduncu FS; Güntner M; Hozaeel W; Reichart A; Jäger E; Kraus T; Mönig S; Bechstein WO; Schuler M; Schmalenberg H; Hofheinz RD;
Lancet; 2019 May; 393(10184):1948-1957. PubMed ID: 30982686
[TBL] [Abstract][Full Text] [Related]
22. Clinical Outcome in Patients with Carcinoma of the Esophagogastric Junction Treated with Neoadjuvant Radiochemotherapy or Perioperative Chemotherapy: A Two-Center Retrospective Analysis.
Wundsam HV; Doleschal B; Prommer R; Venhoda C; Schmitt C; Petzer A; Metz-Gercek S; Rumpold H
Oncology; 2020; 98(10):706-713. PubMed ID: 32516775
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment Algorithm.
Hingorani M; Goody R; Bozas G; Zahid K; Mitton DJ; Jain P; Wong V; Roy R
Oncology; 2023; 101(9):553-564. PubMed ID: 37015204
[TBL] [Abstract][Full Text] [Related]
24. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
Ott K; Bader FG; Lordick F; Feith M; Bartels H; Siewert JR
Ann Surg Oncol; 2009 Apr; 16(4):1017-25. PubMed ID: 19189186
[TBL] [Abstract][Full Text] [Related]
25. Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
Huemer F; Hecht S; Scharinger B; Schlintl V; Rinnerthaler G; Schlick K; Heregger R; Melchardt T; Wimmer A; Mühlbacher I; Koch OO; Neureiter D; Klieser E; Seyedinia S; Beheshti M; Greil R; Weiss L
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3051-3064. PubMed ID: 35864270
[TBL] [Abstract][Full Text] [Related]
26. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.
Woodard GA; Crockard JC; Clary-Macy C; Zoon-Besselink CT; Jones K; Korn WM; Ko AH; Gottschalk AR; Rogers SJ; Jablons DM
J Surg Oncol; 2016 Dec; 114(7):838-847. PubMed ID: 27569043
[TBL] [Abstract][Full Text] [Related]
27. Correlation of primary tumor volume and histopathologic response following neoadjuvant treatment of esophageal adenocarcinoma.
Bremm J; Brunner S; Celik E; Damanakis A; Schlösser H; Fuchs HF; Schmidt T; Zander T; Maintz D; Bruns CJ; Quaas A; Pinto Dos Santos D; Schroeder W
Eur J Surg Oncol; 2024 Apr; 50(4):108003. PubMed ID: 38401351
[TBL] [Abstract][Full Text] [Related]
28. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
29. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO.
Götze TO; Piso P; Lorenzen S; Bankstahl US; Pauligk C; Elshafei M; Amato G; Reim D; Bechstein WO; Königsrainer A; Mönig SP; Rau B; Schwarzbach M; Al-Batran SE
BMC Cancer; 2021 Oct; 21(1):1158. PubMed ID: 34715810
[TBL] [Abstract][Full Text] [Related]
30. Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma - A comparison of the FLOT and 'MAGIC' regimens.
Moore JL; Kumar S; Santaolalla A; Patel PH; Kapiris M; Van Hemelrijck M; Maisey N; Hill M; Lagergren J; Gossage JA; Kelly M; Chaudry A; Allum WH; Baker CR; Cunningham D; Davies AR;
Eur J Cancer; 2022 Mar; 163():180-188. PubMed ID: 35085931
[TBL] [Abstract][Full Text] [Related]
31. [Short term results of the FLOT neoadjuvant therapy on the surgical management of advanced gastro-oesophageal junction adenocarcinoma].
Paszt A; Simonka Z; Budai K; Erdős M; Vas M; Ottlakán A; Szepes Z; Torday L; Tiszlavicz L; Lázár G
Magy Seb; 2022 Jun; 75(2):142-150. PubMed ID: 35895528
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
[TBL] [Abstract][Full Text] [Related]
33. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
34. Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival.
Runkel M; Verst R; Spiegelberg J; Fichtner-Feigl S; Hoeppner J; Glatz T
BMC Surg; 2021 Jan; 21(1):35. PubMed ID: 33435947
[TBL] [Abstract][Full Text] [Related]
35. Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis.
Koch OO; Weitzendorfer M; Varga M; Tschoner A; Partl R; Perathoner A; Gehwolf P; Kapp KS; Függer R; Öfner D; Emmanuel K
World J Surg Oncol; 2019 Aug; 17(1):146. PubMed ID: 31426805
[TBL] [Abstract][Full Text] [Related]
36. Esophagogastric junction adenocarcinoma: Preoperative chemoradiation or perioperative chemotherapy?
Laxague F; Schlottmann F
World J Clin Oncol; 2021 Jul; 12(7):557-564. PubMed ID: 34367928
[TBL] [Abstract][Full Text] [Related]
37. Perioperative therapy with FLOT4 significantly increases survival in patients with gastroesophageal and gastric cancer in a large real-world cohort.
Möhring C; Mańczak A; Timotheou A; Sadeghlar F; Zhou T; Mahn R; Monin MB; Toma M; Feldmann G; Brossart P; Köksal M; Sarria GR; Sommer N; Lingohr P; Jafari A; Kalff JC; Strassburg CP; Gonzalez-Carmona MA
Int J Cancer; 2023 Aug; 153(3):609-622. PubMed ID: 36919950
[TBL] [Abstract][Full Text] [Related]
38. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
39. Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma.
Sinnamon AJ; Mehta R; Saeed S; Lauwers GY; Palm RF; Frakes JM; Hoffe SE; Baldonado JJ; Fontaine JP; Pimiento JM
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686650
[No Abstract] [Full Text] [Related]
40. Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials.
Glatz T; Verst R; Kuvendjiska J; Bronsert P; Becker H; Hoeppner J; Kulemann B
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32824326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
